Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
200
34
39
50
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
1.0%
2 terminated/withdrawn out of 200 trials
96.2%
+9.7% vs industry average
13%
25 trials in Phase 3/4
6%
3 of 50 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (200)
Impact of Day 2 Versus Day 3 Fresh Embryo Transfer on Live Birth Rate in Poor-Prognosis Patients
Role: lead
Cohort Study of Airway Microecology and the Pathogenesis and Evolution of Chronic Obstructive Pulmonary Disease
Role: lead
Development and Validation of the Periodontal Map Derived From IOS and CBCT Registration for Diagnosis and Treatment Planning in Moderate-to-severe Periodontitis
Role: lead
The Impact of Assisted Hatching on Pregnancy Outcomes After Vitrified-Warmed Embryo Transfer in Advanced-age Patients
Role: lead
Resection and Defect Repair of Oral Cancer Aided by Mixed Reality Technology
Role: lead
Taurine's Therapeutic Effect on Acute Radiation-induced Oral Mucositis and Dermatitis
Role: lead
Comparing Cleaning Tools for Full-Arch Implant-Supported Fixed Prostheses
Role: lead
T Cell Lymphoma -Stratified Therapy After Response to First-line Treatment-NR
Role: collaborator
Shanghai Clinical Cohort - Parkinson's Disease (Reserve)
Role: collaborator
Postoperative Radiotherapy Combined With Nimotuzumab Followed by Bemcentinib in High-Risk Patients With Head and Neck Squamous Cell Carcinoma
Role: lead
Golidocitinib Versus Placebo as Maintenance Therapy in PTCL Patients With Response (CR/PR) After First-Line Chemotherapy
Role: collaborator
Bone Barrier Technique for Compromised Immediate Implants
Role: lead
Diagnostic Accuracy of Oral Images, OPGs, Biomarkers and Questionnaires vs. Clinical Assessment for Periodontal Disease (PostNCT07164573)
Role: lead
Clinical Study of GT201 in Combination With PD-1 Inhibitor for Advanced Head and Neck Tumors
Role: collaborator
A Prospective, Single-Arm, Phase II Clinical Study of Neoadjuvant Therapy With Pucotenlimab, Lenvatinib, and Temozolomide for Resectable Head and Neck Mucosal Melanoma (PLT-NAT-HNMM-II)
Role: lead
AI-Assisted Colorimetric Diagnosis of Peri-Implant Mucosal Erythema
Role: lead
De-Escalation Surgery After Immunotherapy in Locally Advanced Head and Neck Squamous Cell Carcinoma
Role: lead
Discovery and Validation of Periodontitis Biomarkers
Role: lead
Dissection of the Superior Mesenteric Artery
Role: collaborator
Comparison of Accuracy of Full-arch Implant Digital and Conventional Impressions.
Role: lead